Barings LLC Sells 9,446 Shares of Corteva, Inc. $CTVA

Barings LLC decreased its position in shares of Corteva, Inc. (NYSE:CTVA) by 12.6% during the first quarter, Holdings Channel reports. The institutional investor owned 65,361 shares of the company’s stock after selling 9,446 shares during the period. Barings LLC’s holdings in Corteva were worth $5,471,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of CTVA. Harris Associates L P grew its holdings in Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares in the last quarter. Norges Bank bought a new position in shares of Corteva during the fourth quarter worth $504,001,000. Northwestern Mutual Wealth Management Co. grew its stake in Corteva by 6,527.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after acquiring an additional 3,100,709 shares in the last quarter. Perpetual Ltd increased its holdings in Corteva by 78,688.5% in the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after acquiring an additional 2,612,459 shares during the last quarter. Finally, Amundi lifted its stake in Corteva by 125.3% in the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after purchasing an additional 1,899,248 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of Corteva stock opened at $86.74 on Friday. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock’s fifty day moving average is $80.74 and its two-hundred day moving average is $78.13. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $87.69. The company has a market capitalization of $58.01 billion, a PE ratio of 51.02, a price-to-earnings-growth ratio of 2.58 and a beta of 0.56.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s payout ratio is 42.35%.

Analyst Upgrades and Downgrades

CTVA has been the subject of several research reports. Jefferies Financial Group increased their price objective on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. BNP Paribas Exane boosted their target price on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. CICC Research increased their price target on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a research note on Monday. Finally, Weiss Ratings raised Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and an average price target of $88.95.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.